DE69940785D1 - Proteinexpressionsvektor und benutzung desselbigen - Google Patents

Proteinexpressionsvektor und benutzung desselbigen

Info

Publication number
DE69940785D1
DE69940785D1 DE69940785T DE69940785T DE69940785D1 DE 69940785 D1 DE69940785 D1 DE 69940785D1 DE 69940785 T DE69940785 T DE 69940785T DE 69940785 T DE69940785 T DE 69940785T DE 69940785 D1 DE69940785 D1 DE 69940785D1
Authority
DE
Germany
Prior art keywords
expression vector
nucleotide sequence
protein expression
downstream side
cloning site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69940785T
Other languages
English (en)
Inventor
Hidetoshi Uemura
Akira Okui
Katsuya Kominami
Nozomi Yamaguchi
Shinichi Mitsui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuso Pharmaceutical Industries Ltd
Original Assignee
Fuso Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuso Pharmaceutical Industries Ltd filed Critical Fuso Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of DE69940785D1 publication Critical patent/DE69940785D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69940785T 1998-11-20 1999-11-19 Proteinexpressionsvektor und benutzung desselbigen Expired - Lifetime DE69940785D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33151598 1998-11-20
PCT/JP1999/006474 WO2000031284A1 (fr) 1998-11-20 1999-11-19 Vecteur d'expression de proteine et utilisation de ce dernier

Publications (1)

Publication Number Publication Date
DE69940785D1 true DE69940785D1 (de) 2009-06-04

Family

ID=18244518

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940785T Expired - Lifetime DE69940785D1 (de) 1998-11-20 1999-11-19 Proteinexpressionsvektor und benutzung desselbigen

Country Status (8)

Country Link
US (1) US7029909B1 (de)
EP (1) EP1132479B1 (de)
JP (1) JP4475814B2 (de)
AT (1) ATE429504T1 (de)
AU (1) AU765111B2 (de)
CA (1) CA2350226C (de)
DE (1) DE69940785D1 (de)
WO (1) WO2000031284A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1399568T3 (da) * 2001-02-01 2006-03-27 Hoffmann La Roche Fremgangsmåde til fremstilling af rekombinant trypsin
AU2002350039A1 (en) 2001-10-29 2003-05-12 Renovis, Inc. Method for isolating cell-type specific mrnas
PL195457B1 (pl) * 2002-08-05 2007-09-28 Zaklady Farm Polpharma Sa Kaseta ekspresyjna, dwucistronowy wektor plazmidowy, środek farmaceutyczny oraz ich zastosowanie
JP2006345831A (ja) * 2005-06-20 2006-12-28 P-Lap:Kk Ｄｎａ、ベクター、形質転換体、及びａｐａタンパク質の製造方法
JP5130662B2 (ja) * 2006-06-07 2013-01-30 Ｊｎｃ株式会社 タンパク質の可溶性タンパク質としての製造方法
US20090252703A1 (en) * 2006-10-19 2009-10-08 Gegg Jr Colin V Use of alcohol co-solvents to improve pegylation reaction yields
PE20081140A1 (es) * 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
MX2009012609A (es) * 2007-05-22 2009-12-07 Amgen Inc Composiciones y metodos para producir proteinas de fusion bioactivas.
JP5670755B2 (ja) 2008-03-12 2015-02-18 ザ ロックフェラー ユニバーシティ 翻訳プロファイリング及び分子表現型解析のための方法及び組成物
EP2432488A4 (de) 2009-03-20 2014-01-08 Amgen Inc Selektive und potente hemmer von kv1.3
TW201129379A (en) 2009-11-20 2011-09-01 Amgen Inc Anti-Orai1 antigen binding proteins and uses thereof
EP2603794A1 (de) 2010-08-10 2013-06-19 Amgen Inc. Doppelfunktions-in-vitro-targetbindungstest für den nachweis von neutralisierenden antikörpern gegen target-antikörper
MX360946B (es) 2010-09-22 2018-10-29 Amgen Inc Star Inmunoglobulinas portadoras y usos de las mismas.
EP2649178B8 (de) * 2010-12-09 2017-08-30 Institut Pasteur Mgmt-basierte methode zur erzielung hoher ausbeute bei rekombinanter proteinexpression
AU2012207366A1 (en) 2011-01-18 2013-07-11 Amgen Inc. Nav1.7 knockout mice and uses thereof
PE20140593A1 (es) 2011-03-16 2014-05-10 Amgen Inc Inhibidores potentes y selectivos de nav1.3 y nav1.7
EP2816893A1 (de) 2012-02-22 2014-12-31 Amgen Inc. Aus induzierten pluripotenten stammzellen gewonnene autologe säugetiere und entsprechende verfahren
US9540657B2 (en) 2012-05-25 2017-01-10 California Institute Of Technology Expression of secreted and cell-surface polypeptides
WO2014165277A2 (en) 2013-03-12 2014-10-09 Amgen Inc. POTENT AND SELECTIVE INHIBITORS OF Nav1.7
WO2015031686A1 (en) 2013-08-30 2015-03-05 Amgen Inc. High titer recombinant aav vector production in adherent and suspension cells
WO2015192009A2 (en) * 2014-06-13 2015-12-17 Whitehead Institute For Biomedical Research Amyloid beta expression constructs and uses therefor
ES2854400T3 (es) 2014-10-13 2021-09-21 Univ Maryland Fc-ELA--32 y su uso en el tratamiento de afecciones cardiacas
ES2900331T3 (es) 2014-10-15 2022-03-16 Amgen Inc Elementos promotores y reguladores para mejorar la expresión de genes heterólogos en células hospederas
KR101787485B1 (ko) * 2015-12-30 2017-11-15 재단법인 의약바이오컨버젼스연구단 재조합 picp 단백질 및 이에 특이적으로 결합하는 항체의 제조방법
US11028410B2 (en) 2016-01-27 2021-06-08 Just-Evotec Biologics, Inc. Hybrid promoter and uses thereof
US11135266B2 (en) 2016-11-21 2021-10-05 Just-Evotec Biologics, Inc. Aflibercept formulations and uses thereof
CN111344410B (zh) 2017-08-17 2023-09-15 济世易为生物有限公司 从宿主细胞半乳糖凝集素和其他污染物中纯化糖基化蛋白的方法
CA3081094A1 (en) 2017-11-20 2019-05-23 Alison J. GILLESPIE Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof
EP3924458A1 (de) 2019-02-15 2021-12-22 Just-Evotec Biologics, Inc. Automatisierte bioherstellungssysteme, anlagen und prozesse
WO2023287707A1 (en) 2021-07-15 2023-01-19 Just-Evotec Biologics, Inc. Bidirectional tangential flow filtration (tff) perfusion system
AU2023219515A1 (en) 2022-02-10 2024-08-08 Amgen Inc. Antibody protein product expression constructs for high throughput sequencing

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3582965B2 (ja) * 1996-08-23 2004-10-27 株式会社イムノ・ジャパン 哺乳動物細胞用発現ベクター

Also Published As

Publication number Publication date
CA2350226C (en) 2012-04-24
EP1132479A4 (de) 2005-08-10
CA2350226A1 (en) 2000-06-02
AU765111B2 (en) 2003-09-11
WO2000031284A1 (fr) 2000-06-02
EP1132479A1 (de) 2001-09-12
JP4475814B2 (ja) 2010-06-09
ATE429504T1 (de) 2009-05-15
AU1184000A (en) 2000-06-13
US7029909B1 (en) 2006-04-18
EP1132479B1 (de) 2009-04-22

Similar Documents

Publication Publication Date Title
DE69940785D1 (de) Proteinexpressionsvektor und benutzung desselbigen
BR0113864A (pt) ácidos nucléicos tipo kcp isolados e suas proteìnas codificadas
RS50364B (sr) Modifikovani faktor viii
NO995901L (no) Vektor
BRPI9912663B8 (pt) vacina contra cáncer e polipeptìdeo.
DK0737207T3 (da) Inhibitorer for humant plasmin afledt af Kunitz-domæner
DE69839444D1 (de) Smad 6 und dessen anwendungen
NO940736L (no) DNA sekvenser som koder for gelonin polypeptid
CY1106978T1 (el) Ενζυμα φωσφοδιεστερασης
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
DK1108786T3 (da) Hidtil ukendt kollektin
SE9602822D0 (sv) New receptor
DK0919621T3 (da) Human TAK1 og DNA der koder derfor
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
NO981707L (no) Xylanase, oligonukleotidsekvens som koder for xylanase og anvendelse derav
ATE186731T1 (de) Anomere fluorribosylamine
IL136496A0 (en) Nucleotide sequences encoding the tomato light hypersensitive phenotype, encoded proteins and uses thereof
FR2710113B1 (fr) Barreau magnétique courbe ou rectiligne, formé d'aimants disjoints.
LV12722A (lv) Prv-1 gene and the use thereof
GB9604518D0 (en) Novel compounds
WO2002022822A3 (en) Plant derived bag homologues
IT1286829B1 (it) Plasmidi contenenti due o piu' competitori disposti in successione e loro uso in tecniche di pcr-competitiva
DE69943149D1 (en) Serinprotease bssp2
ITMI920320A1 (it) Composizione marcante-denaturante particolarmente adatta per marcare e denaturare bitumi combustibili o prodotti affini.
BR0107799A (pt) Proteìna de interação de wt1 wtip

Legal Events

Date Code Title Description
8364 No opposition during term of opposition